Cervical cancer during pregnancy linked to higher maternal health risks

A new research paper was published in Oncoscience’s Volume 12 on January 20, 2025, titled “Maternal, delivery and neonatal outcomes in women with cervical cancer. A study of a population database.”

Roche posts interim OS data from PhIII TIGIT trial after leak — and analysts say it bodes well for final readout

Roche has posted a snapshot from a closely-watched Phase III trial of its TIGIT antibody after an “inadvertent disclosure.” Although the overall survival data are

August 24, 2023

Novartis strengthens radiopharma leadership with Ratio Therapeutics deal – Pharmaceutical Technology

Radiopharmaceutical therapy involves targeting cancer cells with a radioactive drug. Credit: elenabsl via Shutterstock. Novartis is bolstering its leadership in the radiopharmaceutical space by partnering

November 19, 2024

Takeda’s new deal with Kumquat; IL-2 biotech raises $55M

Plus, news about Neurocrine Biosciences, Nxera Pharma, Voyager Therapeutics and Acorda Therapeutics: Takeda inks pact with Kumquat: The San Diego biotech will get up to

April 17, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.